John Long, MD
Ophthalmic Plastic and Reconstructive Surgery · Birmingham, ALNPI 1861495384
Payments from drug & device makers
Across 36 payments — averaging $20.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$356
- AbbVie$68
- Glaukos Corporation$43
- Alcon$41
- Harrow Eye, LLC$40
- Oyster Point Pharma, Inc.$37
- plus $158 from 6 others
What the payments were for
- Food & beverage$742100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 20 | $356 |
| AbbVie | 2 | $68 |
| Glaukos Corporation | 2 | $43 |
| Alcon | 2 | $41 |
| Harrow Eye, LLC | 1 | $40 |
| Oyster Point Pharma, Inc. | 2 | $37 |
| Acumed LLC | 1 | $36 |
| Novartis | 2 | $36 |
| Biotissue Holdings Inc. | 1 | $24 |
| Sun Pharmaceutical Industries Inc. | 1 | $23 |
| Bausch & Lomb Americas Inc. | 1 | $21 |
| Rxsight Inc | 1 | $19 |
How this compares
Too few ophthalmic plastic and reconstructive surgery providers in Alabamato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 287 | $3,969 |
| Prednisolone Acetate | 89 | $3,082 |
| Doxycycline Hyclate | 42 | $727 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 144 | $273 |
| Ciprofloxacin Hcl | 27 | $159 |
| Ketorolac Tromethamine | 35 | $159 |
| Clonazepam | 13 | $99 |
| Diazepam | 30 | $26 |
Paid to pharmacies, not to this prescriber.
Other ophthalmic plastic and reconstructive surgery in Birmingham
- Matthew VicinanzoBirmingham$1K
- Mark BrownMobile$42K
- Carrie MorrisGulf Shores$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.